Robert Chang, Chairman
Currently the President and CEO of Myra Medical, Mr. Chang has more than 30 years of executive and development experience, predominantly in structural heart therapies. Prior to joining Myra, Chang was President and CEO of MVRx, Inc. and prior to that the Executive Vice President and Chief Technology Officer of Sadra Medical prior to its acquisition by Boston Scientific Corporation. Previous to Sadra, Robert co-founded and served as President, CEO and Director of Ample Medical. In the past, Mr. Chang held positions of increasing responsibility at Satiety, IsoStent and Devices for Vascular Intervention. Robert holds a BS from Cal Poly and an MS from MIT both in Mechanical Engineering.